Need help?
news

Circulating tumour DNA tests predictive in pancreatic cancer

More evidence is emerging to support the use of testing for circulating tumour DNA (ctDNA) as a promising way to predict whether a cancer will come back. Tumours release degraded fragments of DNA, including ctDNA, into the bloodstream. Testing a cancer patient’s blood for this DNA, using a type of blood test called a liquid […]

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more